Trial Profile
A phase 2 efficacy and safety study of SU011248 [sunitinib] in patients with non-small cell lung cancer and brain metastases
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2007
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Apr 2007 New trial record.